Renal replacement therapy in the intensive care unit

Area of Science:

• Nephrology
• Critical Care Medicine
• Intensive Care Unit (ICU) Management

Background:

• Acute renal failure (ARF) is a common complication in critically ill patients, associated with significant morbidity and mortality.
• Managing ARF in multi-organ failure differs from single-organ failure, posing unique clinical challenges.
• Conventional intermittent hemodialysis is often poorly tolerated by critically ill patients.

Purpose of the Study:

• To review the management of acute renal failure in critically ill patients.
• To explore the potential of continuous renal replacement therapy (CRRT) and novel hybrid therapies.
• To highlight the need for systematic investigation of emerging hybrid renal replacement strategies.

Main Methods:

• Review of current literature on renal replacement therapy in critically ill patients.
• Comparison of intermittent hemodialysis, continuous renal replacement therapy, and hybrid therapies.
• Discussion of physiological superiority, clinical evidence, and practical considerations of different modalities.

Main Results:

• Continuous renal replacement therapy (CRRT) is physiologically superior but lacks robust clinical benefit evidence.
• Hybrid therapies combine intermittent and continuous modalities, offering flexibility and potential cost-effectiveness.
• Current evidence for hybrid therapies is limited, necessitating further systematic study.

Conclusions:

• Acute renal failure management in critically ill patients requires tailored approaches.
• Hybrid renal replacement therapies present a promising, flexible alternative that needs rigorous investigation.
• Systematic studies are crucial to establish the clinical efficacy and cost-effectiveness of hybrid therapies.